Lantern Pharma
LTRN
LTRN
26 hedge funds and large institutions have $8.06M invested in Lantern Pharma in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
22% less capital invested
Capital invested by funds: $10.4M → $8.06M (-$2.32M)
94% less call options, than puts
Call options by funds: $1K | Put options by funds: $17K
Holders
26
Holding in Top 10
–
Calls
$1K
Puts
$17K
Top Buyers
| 1 | +$65K | |
| 2 | +$64.8K | |
| 3 | +$15.4K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.97K |
| 5 |
GIA
GHP Investment Advisors
Denver,
Colorado
|
+$2K |
Top Sellers
| 1 | -$145K | |
| 2 | -$102K | |
| 3 | -$66K | |
| 4 |
WWM
Wolff Wiese Magana
Carslbad,
California
|
-$26.1K |
| 5 |
JPMorgan Chase & Co
New York
|
-$23.9K |